Cefalo, Graziella <br/><br/>
Temozolomide is an active agent in children with recurrent medulloblastoma/primitive neuroectodermal tumor: an Italian multi-institutional phase II trial.  [electronic resource] 

 -  Neuro-oncology  May 2014 
 - 748-53 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1523-5866 
<br/><br/><label>Standard No.: </label>10.1093/neuonc/not320  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antineoplastic Agents, Alkylating--adverse effects<br/>Cerebellar Neoplasms--drug therapy<br/>Child<br/>Child, Preschool<br/>Dacarbazine--adverse effects<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Italy<br/>Male<br/>Medulloblastoma--drug therapy<br/>Neoplasm Recurrence, Local--drug therapy<br/>Neuroectodermal Tumors, Primitive--drug therapy<br/>Temozolomide<br/>Young Adult